This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include: Allison Transmission, Restoration Hardware, Cigna, Encompass Health and O???Reilly Automotive
by Zacks Equity Research
Zacks.com featured highlights include: Allison Transmission, Restoration Hardware, Cigna, Encompass Health and O???Reilly Automotive
5 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Encompass Health Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Encompass Health Corporation (EHC) has been struggling lately, but the selling pressure may be coming to an end soon.
3 Medical Stocks Likely to Emulate Illumina's Success in 2019
by Urmimala Biswas
Illumina's (ILMN) gains are indeed staggering. But is it the sole star in the firmament setting benchmarks for others to try and emulate?
EHC vs. CHE: Which Stock Is the Better Value Option?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
Encompass Health Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Encompass Health has been struggling lately, but the selling pressure may be coming to an end soon.
EHC vs. CHE: Which Stock Is the Better Value Option?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
Is Encompass Health (EHC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EHC vs. USPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EHC vs. USPH: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Allison Transmission, S&T Bancorp, Encompass Health and Celanese
by Zacks Equity Research
Zacks.com featured highlights include: Allison Transmission, S&T Bancorp, Encompass Health and Celanese
4 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Encompass Health (EHC) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 15.19% and 0.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Encompass Health (EHC) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EHC or CHE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
4 Stocks to Bet on the Burgeoning Home Healthcare Industry
by Sapna Bagaria
Growing senior population, increasing chronic illness, high cost of treatment at inpatient settings and preference by patients drives demand for home health care.
EHC or CHE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
EHC vs. CHE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
EHC vs. CHE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
EHC vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
EHC vs. USPH: Which Stock Is the Better Value Option?
Is Encompass Health (EHC) a Great Stock for Value Investors Right Now?
by Zacks Equity Research
Encompass Health (EHC) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Encompass Health (EHC) Hits Fresh Highs: Is There Still Room to Run?
by Zacks Equity Research
Encompass Health Corporation is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for EHC for clues.